[Malignant atrophic papulosis].
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000473:pathology*; D005938:Glucocorticoids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007410:Intestinal Diseases / Q000209:etiology; D007416:Intestinal Perforation / Q000209:etiology; D007422:Intestines / Q000473:pathology; D012867:Skin / Q000098:blood supply / Q000473:pathology; D012871:Skin Diseases / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D012883:Skin Ulcer / Q000209:etiology; D013449:Sulfonamides / Q000627:therapeutic use; D013927:Thrombosis / Q000209:etiology*
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D013449:Sulfonamides; D006493:Heparin
La papulose atrophiante maligne